Suppliers / Inner Mongolia Jingdong Pharmaceutical

Inner Mongolia Jingdong Pharmaceutical

China Updated 9 July 2026

Inner Mongolia Jingdong Pharmaceutical is an API manufacturer based in China. It holds one active US drug master file.

1
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Eslicarbazepine Acetate US FDA 1

Also appears on these molecule pages

Eslicarbazepine API

Questions about Inner Mongolia Jingdong Pharmaceutical

Does Inner Mongolia Jingdong Pharmaceutical hold a US DMF or a CEP?
Inner Mongolia Jingdong Pharmaceutical holds 1 active US drug master file. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Inner Mongolia Jingdong Pharmaceutical make?
1 molecule is on record against Inner Mongolia Jingdong Pharmaceutical, including Eslicarbazepine Acetate. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Inner Mongolia Jingdong Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Apitoria Pharma shares 1 molecule Dr Reddy's Laboratories shares 1 molecule Jubilant Biosys shares 1 molecule Lupin shares 1 molecule Cohance Lifesciences shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability